- Home
- RPRX vs BAP Comparison
RPRX vs BAP Comparison
Compare RPRX & BAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RPRX | BAP |
|---|---|---|
| Founded | 1996 | 1889 |
| Country | United States | Peru |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.4B | 21.1B |
| IPO Year | 2020 | 1997 |
Fundamental Metrics
Financial Performance| Metric | RPRX | BAP |
|---|---|---|
| Price | $46.03 | $341.40 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 5 |
| Target Price | $47.75 | ★ $291.60 |
| AVG Volume (30 Days) | ★ 3.2M | 521.9K |
| Earning Date | 05-06-2026 | 01-01-0001 |
| Dividend Yield | 2.07% | ★ 3.33% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.78 | N/A |
| Revenue | ★ $2,378,193,000.00 | N/A |
| Revenue This Year | $38.30 | $22.58 |
| Revenue Next Year | $4.80 | $8.84 |
| P/E Ratio | $25.56 | ★ $12.91 |
| Revenue Growth | ★ 5.06 | N/A |
| 52 Week Low | $29.66 | $165.51 |
| 52 Week High | $47.86 | $380.20 |
Technical Indicators
Market Signals| Indicator | RPRX | BAP |
|---|---|---|
| Relative Strength Index (RSI) | 61.06 | 51.60 |
| Support Level | $35.32 | $253.23 |
| Resistance Level | $46.14 | $360.83 |
| Average True Range (ATR) | 0.88 | 11.72 |
| MACD | -0.19 | -2.62 |
| Stochastic Oscillator | 43.64 | 56.26 |
Price Performance
Historical ComparisonAbout RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About BAP Credicorp Ltd.
Credicorp Ltd is a Peruvian financial services company. It operates in four business lines, including Universal Banking, Insurance and Pensions, Microfinance, and Investment Management & Advisory. Its subsidiaries include Banco de Credito del Peru, Prima AFP, and Credicorp Capital. Geographically, the company operates in Peru, Colombia, Bolivia, Chile, Panama, the USA, and Mexico; the majority of its revenue is generated from Peru.